Beginning January 1, 2027, prescription drug wholesalers and retailers would use set business-tax rates, while qualifying small pharmacies would use a lower rate.
Businesses that warehouse and resell prescription drugs would pay set tax rates on that income: 0.5 percent in 2027 and 0.35 percent starting in 2028.
Eligible independent pharmacies serving isolated, tribal, high-poverty, or otherwise underserved areas would pay a 0.138 percent tax on retail sales.
Drug wholesalers and retailers would pay a business tax on income from warehousing and reselling prescription drugs. The rule covers prescription drugs for human use bought from a manufacturer or wholesaler and resold to retailers, hospitals, clinics, health care providers, or other health care service providers. The business must be registered with the federal Drug Enforcement Administration and licensed by the pharmacy quality assurance commission. The tax rate would be 0.5 percent during calendar year 2027 and 0.35 percent beginning January 1, 2028. The provision would apply beginning January 1, 2027, with the lower rate applying beginning January 1, 2028.
Critical access pharmacies would pay a 0.138 percent business tax on retail sales. The rate covers independent pharmacies that are at least 25 miles from another pharmacy, are the only pharmacy on an island, are operated by a tribe, are the only pharmacy in a high-poverty census tract, or appear on the state health care authority's critical access pharmacy list by July 1, 2026. An independent pharmacy cannot be owned or operated by a subsidiary or affiliate of a large for-profit pharmacy company, a pharmacy benefit manager, or a publicly traded company. The pharmacy must make retail sales to use this rate. The rate would apply beginning January 1, 2027; the list-based eligibility condition includes pharmacies listed on or before July 1, 2026.
No hearings or votes scheduled.